141 related articles for article (PubMed ID: 35677367)
41. The Contractile Effects of Oxytocin, Ergonovine, and Carboprost and Their Combinations: an In Vitro Study on Human Myometrial Strips.
Balki M; Erik-Soussi M; Ramachandran N; Kingdom J; Carvalho JCA
Anesth Analg; 2015 May; 120(5):1074-1084. PubMed ID: 25822922
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of carboprost tromethamine combined with leonurus japonicus for prevention of postpartum hemorrhage in high-risk pregnant women: A protocol for systematic review and meta-analysis.
Zong F; Cao Y
Medicine (Baltimore); 2021 Jul; 100(30):e26792. PubMed ID: 34397731
[TBL] [Abstract][Full Text] [Related]
43. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage.
Leduc D; Senikas V; Lalonde AB;
J Obstet Gynaecol Can; 2009 Oct; 31(10):980-993. PubMed ID: 19941729
[TBL] [Abstract][Full Text] [Related]
44. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.
Salati JA; Leathersich SJ; Williams MJ; Cuthbert A; Tolosa JE
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD001808. PubMed ID: 31032882
[TBL] [Abstract][Full Text] [Related]
45. A retrospective study of estrogen in the pretreatment for medical management of early pregnancy loss and the inference from intrauterine adhesion.
Cao C; Zhou Q; Hu Z; Shu C; Chen M; Yang X
Eur J Med Res; 2022 Jul; 27(1):129. PubMed ID: 35879721
[TBL] [Abstract][Full Text] [Related]
46. Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery.
Gerstenfeld TS; Wing DA
Am J Obstet Gynecol; 2001 Oct; 185(4):878-82. PubMed ID: 11641670
[TBL] [Abstract][Full Text] [Related]
47. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: a descriptive study.
O'Brien P; El-Refaey H; Gordon A; Geary M; Rodeck CH
Obstet Gynecol; 1998 Aug; 92(2):212-4. PubMed ID: 9699753
[TBL] [Abstract][Full Text] [Related]
48. Intravenous oxytocin dosing regimens for postpartum hemorrhage prevention following cesarean delivery: a systematic review and meta-analysis.
Phung LC; Farrington EK; Connolly M; Wilson AN; Carvalho B; Homer CSE; Vogel JP
Am J Obstet Gynecol; 2021 Sep; 225(3):250.e1-250.e38. PubMed ID: 33957113
[TBL] [Abstract][Full Text] [Related]
49. The risk of postpartum hemorrhage when lowering the oxytocin dose in planned cesarean section, a pilot study.
Stålberg V; Josefsson A; Bladh M; Lilliecreutz C
Sex Reprod Healthc; 2021 Sep; 29():100641. PubMed ID: 34174496
[TBL] [Abstract][Full Text] [Related]
50. Simultaneous determination of carboprost methylate and its active metabolite carboprost in dog plasma by liquid chromatography-tandem mass spectrometry with positive/negative ion-switching electrospray ionization and its application to a pharmacokinetic study.
Yin L; Meng X; Zhou X; Zhang T; Sun H; Yang Z; Yang B; Xiao N; Fawcett JP; Yang Y; Gu J
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 998-999():8-14. PubMed ID: 26149245
[TBL] [Abstract][Full Text] [Related]
51. The Salford Third Stage Trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor.
Mitchell GG; Elbourne DR
Online J Curr Clin Trials; 1993 Aug; Doc No 83():[2305 words; 32 paragraphs]. PubMed ID: 8306013
[TBL] [Abstract][Full Text] [Related]
52. A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage.
Chaudhuri P; Majumdar A
Int J Gynaecol Obstet; 2016 Feb; 132(2):191-5. PubMed ID: 26613819
[TBL] [Abstract][Full Text] [Related]
53. Effect of Hydroalcoholic Extract of Capsella bursa pastoris on Early Postpartum Hemorrhage: A Clinical Trial Study.
Ghalandari S; Kariman N; Sheikhan Z; Mojab F; Mirzaei M; Shahrahmani H
J Altern Complement Med; 2017 Oct; 23(10):794-799. PubMed ID: 28590768
[TBL] [Abstract][Full Text] [Related]
54. Oxytocin receptor single nucleotide polymorphism predicts atony-related postpartum hemorrhage.
Erickson EN; Krol KM; Perkeybile AM; Connelly JJ; Myatt L
BMC Pregnancy Childbirth; 2022 Nov; 22(1):884. PubMed ID: 36447139
[TBL] [Abstract][Full Text] [Related]
55. Prevention of postpartum hemorrhage, safety and efficacy.
Abu-Omar AA
Saudi Med J; 2001 Dec; 22(12):1118-21. PubMed ID: 11802188
[TBL] [Abstract][Full Text] [Related]
56. Rectal misoprostol versus intramuscular oxytocin for prevention of post partum hemorrhage.
Shrestha A; Dongol A; Chawla CD; Adhikari RK
Kathmandu Univ Med J (KUMJ); 2011; 9(33):8-12. PubMed ID: 22610801
[TBL] [Abstract][Full Text] [Related]
57. A Standardized Postpartum Oxytocin Protocol to Reduce Hemorrhage Treatment: Outcomes by Delivery Mode.
Seagraves E; Kenny TH; Doyle JL; Gothard MD; Silber A
Jt Comm J Qual Patient Saf; 2019 Nov; 45(11):733-741. PubMed ID: 31623991
[TBL] [Abstract][Full Text] [Related]
58. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin.
Rath W
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):15-20. PubMed ID: 19616358
[TBL] [Abstract][Full Text] [Related]
59. Cervical dilation balloon combined with intravenous drip of oxytocin for induction of term labor: a multicenter clinical trial.
Wu X; Wang C; Li Y; Ouyang C; Liao J; Cai W; Zhong Y; Zhang J; Chen H
Arch Gynecol Obstet; 2018 Jan; 297(1):77-83. PubMed ID: 29043436
[TBL] [Abstract][Full Text] [Related]
60. A double-blinded, randomized controlled trial of oxytocin at the beginning versus the end of the third stage of labor for prevention of postpartum hemorrhage.
Huh WK; Chelmow D; Malone FD
Gynecol Obstet Invest; 2004; 58(2):72-6. PubMed ID: 15103233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
